Vanguard Group Inc Mersana Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 7,177,458 shares of MRSN stock, worth $18.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,177,458

Previous 6,702,521 7.09%

Holding current value

$18.1 Million

Previous $13.5 Million 0.69%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.23 - $2.25 $584,172 - $1.07 Million	474,937 Added 7.09%	7,177,458 $13.6 Million
Q2 2024 Aug 13, 2024	BUY	$2.0 - $4.45 $856,302 - $1.91 Million	428,151 Added 6.82%	6,702,521 $13.5 Million
Q1 2024 May 10, 2024	BUY	$2.16 - $5.94 $79,449 - $218,485	36,782 Added 0.59%	6,274,370 $28.1 Million
Q4 2023 Feb 14, 2024	BUY	$1.11 - $2.34 $57,126 - $120,428	51,465 Added 0.83%	6,237,588 $14.5 Million
Q3 2023 Nov 14, 2023	BUY	$1.06 - $3.91 $489,194 - $1.8 Million	461,504 Added 8.06%	6,186,123 $7.86 Million
Q2 2023 Aug 14, 2023	BUY	$3.08 - $9.55 $3.35 Million - $10.4 Million	1,086,127 Added 23.42%	5,724,619 $18.8 Million
Q1 2023 May 15, 2023	BUY	$4.0 - $7.02 $757,808 - $1.33 Million	189,452 Added 4.26%	4,638,492 $19.1 Million
Q4 2022 Feb 10, 2023	BUY	$5.65 - $7.86 $401,381 - $558,382	71,041 Added 1.62%	4,449,040 $26.1 Million
Q3 2022 Nov 14, 2022	SELL	$4.63 - $8.0 $1.65 Million - $2.85 Million	-355,732 Reduced 7.51%	4,377,999 $29.6 Million
Q2 2022 Aug 12, 2022	BUY	$2.84 - $5.0 $3.69 Million - $6.49 Million	1,298,461 Added 37.8%	4,733,731 $21.9 Million
Q1 2022 May 13, 2022	SELL	$3.74 - $6.63 $643,882 - $1.14 Million	-172,161 Reduced 4.77%	3,435,270 $13.7 Million
Q4 2021 Feb 14, 2022	SELL	$5.48 - $9.86 $406,413 - $731,247	-74,163 Reduced 2.01%	3,607,431 $22.4 Million
Q3 2021 Nov 12, 2021	BUY	$8.56 - $14.47 $4.28 Million - $7.24 Million	500,009 Added 15.72%	3,681,594 $34.7 Million
Q2 2021 Aug 13, 2021	BUY	$13.28 - $18.07 $42.3 Million - $57.5 Million	3,181,585 New	3,181,585 $43.2 Million

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

74K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $245M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Mersana Therapeutics, Inc. Transaction History